
National Nurses United (NNU) reported that nurses in the New Orleans area approve of the Federal Trade Commission’s (FTC) decision to prevent the proposed agreement between HCA Healthcare and LCMC Health.
The proposed acquisition has been met with opposition from nurses, and the FTC is conducting a review to assess potential violations of federal antitrust laws. The proposed deal’s impact on healthcare costs and access in New Orleans is a concern.
“We’re glad to see the FTC’s intervention,” said Calia Chavis, RN, who works in Tulane’s Abdominal Transplant Unit. “Nurses know that consolidation is bad for our community. LCMC has already said that they intend to close Tulane Medical Center, leaving an important part of our city without access to care. We’re hopeful that a proper review of this deal will find that it’s a bad deal for the people of New Orleans, as it threatens to destroy vital health care services.”
Read more: DOJ Indicts Health Care Exec For Fixing Wages Of Nurses
“Consolidation like this means service shutdowns, and anti-competitive business moves like this mean increased prices for our patients, who already struggle to get and afford the care that they need and deserve,” said Mea Ratcliff, RN, who works in Tulane’s Transplant Clinic. “Make no mistake, mergers and acquisitions like this only serve to increase profits for corporate healthcare at the expense of patients, nurses, and communities.”
Nurses believe LCMC’s proposed acquisition of Tulane Medical Center in New Orleans, Tulane Lakeside Hospital in Metairie, La., and Lakeview Regional Medical Center in Covington, La., represents a serious threat to healthcare access and costs in New Orleans and beyond.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas